NEW DOSAGE REGIMEN IN CASE OF CONCURRENT INTAKE OF GABAPENTIN WITH FOOD AND AN INCREASED ORAL BIOAVAILABILITY THEREWITH

摘要

The present invention relates to the use of a gabapentin containing controlled-release oral dosage form for the manufacture of a medicament for once-dailly administration and consuming food within one hour after gabapentin intake for treating conditions for which gabapentin is indicated.